<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) are widely associated with <z:mp ids='MP_0005048'>thrombosis</z:mp>, <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortions</z:e> and a <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was first to evaluate the prevalence of <z:hpo ids='HP_0001627'>cardiac abnormalities</z:hpo> in patients with SLE and secondly to establish the relationship between the findings and the presence of an <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>SUBJECTS AND METHODS: First of <z:hpo ids='HP_0000001'>all</z:hpo>, a total of 52 consecutive patients with SLE and 52 healthy sex-and-age-matched control subjects were evaluated in a cross sectional study </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> underwent M mode and two dimensional echocardiography, color flow imaging, pulsed and continuous wave Doppler </plain></SENT>
<SENT sid="4" pm="."><plain>Secondly, in the SLE group, subjects exposed to <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (n = 20) were compared to the control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Compared with the control group, patients with SLE had significantly more pericardial abnormalities [(p = 0.0006) RR [3.36-infinity], <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> [(p = 0.032) RR 2.48 [1.25-5.6]], <z:hpo ids='HP_0005180'>tricuspid regurgitation</z:hpo> [(p = 0.0016) RR 2.41 [1.58-8.85] </plain></SENT>
<SENT sid="6" pm="."><plain>There was no significant difference between both groups for the left ventricular mass (p = 0.07), posterior wall (p = 0.25) and interventricular septum dimension (p = 0.16), and mitral valve thickness (p = 0.66) </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was significantly associated with increased left ventricular mass (p = 0.0054), posterior wall (p = 0.022) and interventricular septum dimension (p = 0.026) </plain></SENT>
<SENT sid="8" pm="."><plain>The relative risk increased for tricuspid and <z:mp ids='MP_0006048'>pulmonary regurgitation</z:mp> in SLE patients who had the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The prevalence of <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> and right heart valvular regurgitation is significantly raised in SLE patients who have the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>However, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> does not modify the prevalence of pericardial abnormalities which seems to be due to SLE alone </plain></SENT>
</text></document>